Ferroptosis in Human Diseases: Molecular Mechanisms, Clinical Biomarkers, and Emerging Therapeutic Strategies
DOI:
https://doi.org/10.59278/cbs.v5i14.108Keywords:
Ferroptosis, Iron metabolism, Lipid peroxidation, Biomarkers, Oxidative stress, Therapeutic strategiesAbstract
Background: Ferroptosis is a distinct form of regulated cell death characterized by iron-dependent lipid peroxidation and disruption of cellular redox homeostasis. Unlike apoptosis, necroptosis, and pyroptosis, ferroptosis is primarily driven by dysregulated iron metabolism, excessive reactive oxygen species generation, and impaired antioxidant defense systems, making it a critical mechanism in the pathogenesis of numerous human diseases. Aim: This narrative review summarizes current advances in the molecular mechanisms, biomarkers, and emerging therapeutic strategies targeting ferroptosis. Methods: Relevant literature published between 2021 and 2026 was retrieved from PubMed, Scopus, and ScienceDirect and qualitatively analyzed. Results: Current evidence indicates that ferroptosis is regulated by coordinated interactions among iron metabolism, lipid remodeling, mitochondrial function, and antioxidant defense pathways, including the System Xc⁻/glutathione/glutathione peroxidase 4 (GPX4) axis, ferroptosis suppressor protein 1 (FSP1), dihydroorotate dehydrogenase (DHODH), and GTP cyclohydrolase 1 (GCH1). Dysregulation of these pathways contributes to cancer, neurodegenerative, cardiovascular, kidney, liver, metabolic, and inflammatory diseases. Several ferroptosis-associated molecular and biochemical indicators, including GPX4, SLC7A11, ACSL4, transferrin receptor 1, ferritin, malondialdehyde, and 4-hydroxynonenal, have been investigated in experimental and clinical disease contexts; however, their specificity for ferroptotic cell death remains insufficiently established. Conclusion: Although ferroptosis-targeted interventions have demonstrated promising effects in experimental and preclinical models, clinical translation remains limited by disease heterogeneity, the absence of standardized ferroptosis-specific biomarkers, uncertainties regarding therapeutic selectivity and toxicity, and limited clinical evidence.
References
1. Hughes LD, Wang Y, Meli AP, Rothlin C V., Ghosh S. Decoding Cell Death: From a Veritable Library of Babel to Vade Mecum ? Annu Rev Immunol. 2021;39(1):791-817. doi:10.1146/annurev-immunol-102819-072601
2. Qian S, Long Y, Tan G, et al. Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets. MedComm. 2024;5(12). doi:10.1002/mco2.70024
3. Snyder AG, Oberst A. The Antisocial Network: Cross Talk Between Cell Death Programs in Host Defense. Annu Rev Immunol. 2021;39(1):77-101. doi:10.1146/annurev-immunol-112019-072301
4. Chen Y, Li X, Yang M, Liu SB. Research progress on morphology and mechanism of programmed cell death. Cell Death Dis. 2024;15(5):327. doi:10.1038/s41419-024-06712-8
5. Wang S, Guo S, Guo J, et al. Cell death pathways: molecular mechanisms and therapeutic targets for cancer. MedComm. 2024;5(9). doi:10.1002/mco2.693
6. Yuan J, Ofengeim D. A guide to cell death pathways. Nat Rev Mol Cell Biol. 2024;25(5):379-395. doi:10.1038/s41580-023-00689-6
7. Glover HL, Schreiner A, Dewson G, Tait SWG. Mitochondria and cell death. Nat Cell Biol. 2024;26(9):1434-1446. doi:10.1038/s41556-024-01429-4
8. Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 2024;25(6):424-442. doi:10.1038/s41580-024-00703-5
9. Zhang DD. Ironing out the details of ferroptosis. Nat Cell Biol. 2024;26(9):1386-1393. doi:10.1038/s41556-024-01361-7
10. Dai E, Chen X, Linkermann A, et al. A guideline on the molecular ecosystem regulating ferroptosis. Nat Cell Biol. 2024;26(9):1447-1457. doi:10.1038/s41556-024-01360-8
11. Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266-282. doi:10.1038/s41580-020-00324-8
12. Zheng J, Conrad M. Ferroptosis: when metabolism meets cell death. Physiol Rev. 2025;105(2):651-706. doi:10.1152/physrev.00031.2024
13. Nakamura T, Conrad M. Exploiting ferroptosis vulnerabilities in cancer. Nat Cell Biol. 2024;26(9):1407-1419. doi:10.1038/s41556-024-01425-8
14. Zhou Q, Meng Y, Le J, et al. Ferroptosis: mechanisms and therapeutic targets. MedComm. 2024;5(12). doi:10.1002/mco2.70010
15. Zhang L, Luo YL, Xiang Y, et al. Ferroptosis inhibitors: past, present and future. Front Pharmacol. 2024;15. doi:10.3389/fphar.2024.1407335
16. Ru Q, Li Y, Chen L, Wu Y, Min J, Wang F. Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects. Signal Transduct Target Ther. 2024;9(1):271. doi:10.1038/s41392-024-01969-z
17. Maremonti F, Tonnus W, Gavali S, et al. Ferroptosis-based advanced therapies as treatment approaches for metabolic and cardiovascular diseases. Cell Death Differ. 2024;31(9):1104-1112. doi:10.1038/s41418-024-01350-1
18. Jiang M, Wu S, Xie K, Zhou G, Zhou W, Bao P. The significance of ferroptosis in renal diseases and its therapeutic potential. Heliyon. 2024;10(16):e35882. doi:10.1016/j.heliyon.2024.e35882
19. Mao ZH, Gao ZX, Pan SK, Liu DW, Liu ZS, Wu P. Ferroptosis: a potential bridge linking gut microbiota and chronic kidney disease. Cell Death Discov. 2024;10(1):234. doi:10.1038/s41420-024-02000-8
20. Zhou Q, Meng Y, Li D, et al. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther. 2024;9(1):55. doi:10.1038/s41392-024-01769-5
21. Wang X, Ren X, Lin X, et al. Recent progress of ferroptosis in cancers and drug discovery. Asian J Pharm Sci. 2024;19(4):100939. doi:10.1016/j.ajps.2024.100939
22. Ma W, Hu N, Xu W, Zhao L, Tian C, Kamei K ichiro. Ferroptosis inducers: A new frontier in cancer therapy. Bioorg Chem. 2024;146:107331. doi:10.1016/j.bioorg.2024.107331
23. Kong Y, Li J, Lin R, et al. Understanding the unique mechanism of ferroptosis: a promising therapeutic target. Front Cell Dev Biol. 2024;11. doi:10.3389/fcell.2023.1329147
24. Chen X, Tsvetkov AS, Shen HM, et al. International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis. Autophagy. 2024;20(6):1213-1246. doi:10.1080/15548627.2024.2319901
25. Li W, Liang L, Liu S, Yi H, Zhou Y. FSP1: a key regulator of ferroptosis. Trends Mol Med. 2023;29(9):753-764. doi:10.1016/j.molmed.2023.05.013
26. Chen F, Kang R, Tang D, Liu J. Ferroptosis: principles and significance in health and disease. J Hematol Oncol. 2024;17(1):41. doi:10.1186/s13045-024-01564-3
27. Li Z, Lange M, Dixon SJ, Olzmann JA. Lipid Quality Control and Ferroptosis: From Concept to Mechanism. Annu Rev Biochem. 2024;93(1):499-528. doi:10.1146/annurev-biochem-052521-033527
28. Xie X, Pang Q, Luo L. Post-translational modifications in ferroptosis: mechanisms and therapeutic potential. Int J Biol Sci. 2026;22(4):1868-1905. doi:10.7150/ijbs.120624
29. Sun K, Zhi Y, Ren W, et al. The mitochondrial regulation in ferroptosis signaling pathway and its potential strategies for cancer. Biomed Pharmacother. 2023;169:115892. doi:10.1016/j.biopha.2023.115892
30. Jin X, Tang J, Qiu X, et al. Ferroptosis: Emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation. Cell Death Discov. 2024;10(1):45. doi:10.1038/s41420-024-01825-7
31. Alves F, Lane D, Nguyen TPM, Bush AI, Ayton S. In defence of ferroptosis. Signal Transduct Target Ther. 2025;10(1):2. doi:10.1038/s41392-024-02088-5
32. Ge A, He Q, Zhao D, et al. Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis. J Cell Mol Med. 2024;28(1). doi:10.1111/jcmm.18044
33. Pang Q, Tang Z, Luo L. The crosstalk between oncogenic signaling and ferroptosis in cancer. Crit Rev Oncol Hematol. 2024;197:104349. doi:10.1016/j.critrevonc.2024.104349
34. Saxena R, Welsh CM, He YW. Targeting regulated cell death pathways in cancers for effective treatment: a comprehensive review. Front Cell Dev Biol. 2024;12. doi:10.3389/fcell.2024.1462339
35. Soni P, Ammal Kaidery N, Sharma SM, et al. A critical appraisal of ferroptosis in Alzheimer’s and Parkinson’s disease: new insights into emerging mechanisms and therapeutic targets. Front Pharmacol. 2024;15. doi:10.3389/fphar.2024.1390798
36. Liu Y, Lu S, Wu L lei, Yang L, Yang L, Wang J. The diversified role of mitochondria in ferroptosis in cancer. Cell Death Dis. 2023;14(8):519. doi:10.1038/s41419-023-06045-y
37. Chen Z, Lin H, Wang X, et al. The application of approaches in detecting ferroptosis. Heliyon. 2024;10(1):e23507. doi:10.1016/j.heliyon.2023.e23507
38. Veeckmans G, Van San E, Vanden Berghe T. A guide to ferroptosis, the biological rust of cellular membranes. FEBS J. 2024;291(13):2767-2783. doi:10.1111/febs.16993
39. Ai Y, Meng Y, Yan B, Zhou Q, Wang X. The biochemical pathways of apoptotic, necroptotic, pyroptotic, and ferroptotic cell death. Mol Cell. 2024;84(1):170-179. doi:10.1016/j.molcel.2023.11.040
40. Berndt C, Alborzinia H, Amen VS, et al. Ferroptosis in health and disease. Redox Biol. 2024;75:103211. doi:10.1016/j.redox.2024.103211
Downloads
Published
Issue
Section
License
Copyright (c) 2026 International Journal of Cell and Biomedical Science

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.









